Stock Taper
EXOZ
EXOZYMES, INC.
NASDAQ
$7.17
▼ DOWN 0.10% (-0.01)

KEY STATISTICS

Market Cap$66.53 M
52w High$18.40
52w Low$4.35
Dividend Yield
Frequency
P/E-6.23
Volume2.69K
Shares Out.9.28M

COMPANY

LEADERSHIP

Michael Heltzen
CHIEF EXECUTIVE
Michael Heltzen

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 13, 2024
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
32

PRICE

$7.17 ▼ DOWN 0.10% (−$0.01)
$6.80$7.00$7.20$7.409:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM7.17

About eXoZymes, Inc.

https://exozymes.com ↗

eXoZymes, Inc., founded in 2014 in Monrovia, California, develops the SimplePath platform, utilizing enzyme modules for biocatalytic production of chemicals, pharmaceuticals, fuels, materials, and food additives.

INDUSTRY

Biotechnology

A SERVICE EXOZYMES, INC. IS KNOWN FOR

Exozyme Biomanufacturing Platform

A cell-free biomanufacturing platform using AI-engineered exozymes to sustainably produce high-value chemicals for pharma, nutraceuticals, and biofuels, offering a scalable alternative to traditional petrochemical and cell-based methods.

ETFS HOLDING THIS STOCK

ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

OFFICER: CHIEF COMMERCIAL OFFICER
Perriman Damien Alan
Sale · 19.6K shares
2026-08-19
OFFICER: CHIEF COMMERCIAL OFFICER
Perriman Damien Alan
Purchase · 19.6K shares
2026-08-19
OFFICER: CHIEF SCIENTIFIC OFFICER
Korman Tyler Paz
Purchase · 33.0K shares
2026-08-19
OFFICER: CHIEF SCIENTIFIC OFFICER
Korman Tyler Paz
Sale · 33.0K shares
2026-08-19

SECTORS PEERS

PEERPRICE
GLSI$15.67COMPARE
SRZN$22.42COMPARE
CGTX$1.02COMPARE
ONCY$0.86COMPARE
TLSA$1.01COMPARE
TIL$7.58COMPARE
ESLA$0.71COMPARE
TVGN$6.89COMPARE